HeartSine samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
HeartSine Technologies Ltd · Decision date Sep 17, 2025
What did the FDA approve?
FDA records P160008/S027 as a supplement to PMA P160008, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 17, 2025.
FDA approval order statement
approval for a minor software change for the SAM 350P and SAM 450P defibrillator models (Version 4.0.6 and 6.0.4, respectively).
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 17, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P160008/S027
- Regulatory pathway
- PMA supplement
- Applicant
- HeartSine Technologies Ltd
- Product code
- MKJ
- Decision code
- APPR
- Decision date
- Sep 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- HeartSine Technologies Ltd
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P160008/S027 received
Application receipt date recorded by FDA.
P160008/S028 · Related supplement
HeartSine Technologies LLC's samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P)
P160008/S029 · Related supplement
HeartSines samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
P160008/S027 · FDA decision
Real-Time Process
P160008/S030 · Related supplement
HeartSine Technologies LLC's samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P)
P160008/S031 · Related supplement
samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
P160008/S032 · Related supplement
HeartSines samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
P160008/S033 · Related supplement
HeartSines samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
P160008/S034 · Related supplement
HeartSine samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P) and Accessories
P160008/S035 · Related supplement
HeartSine samaritan (SAM) Public Access Defibrillator (PAD) SAM 350P, SAM 360P and SAM 450P and Accessories
Timeline entries are records held by MedtechLedger for P160008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| HeartSine Technologies Ltd | PMA supplement | Aug 27, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Sep 2, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Sep 29, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Dec 22, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Jan 8, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | May 7, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | May 18, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Jun 22, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
HeartSine Technologies Ltd
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 207 Airport Rd. W., Belfast, BT3 9ED
Sources and methodology
- Original FDA record: P160008/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





